Clinical Medicine

Listando 62 trabajos del autor/autora 38

Lista de trabajos en el área Clinical Medicine

Mentions 644 Twitter 0 Wikipedia 75 News 2 Policy

Article Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer Moore, K.; Colombo, N.; Scambia, G.; Kim, B. -G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; Banerjee, S.; Oza, A.; Gonzalez-Martin, A.; Aghajanian, C.; Bradley, W.; Mathews, C.; Liu, J.; Lowe, E. S.; B NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2018) DOI / 10.1056/nejmoa1810858 Green published, Bronze

Mentions 107 Twitter 0 Wikipedia 18 News 0 Policy

Article Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer Coleman, R. L.; Fleming, G. F.; Brady, M. F.; Swisher, E. M.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; Moore, K. N.; Ben-Baruch, N. Efrat; Werner, T. L.; Cloven, N. G.; Oaknin, A.; Disilvestro, P. A.; Morgan, M. A.; Nam, J. -H.; Leath, C. A., III; NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2019) DOI / 10.1056/nejmoa1909707 Green published, Green accepted, Bronze

Mentions 94 Twitter 1 Wikipedia 15 News 1 Policy

Review Cervical cancer Cohen, Paul A.; Jhingran, Anjua; Oaknin, Ana; Denny, Lynette LANCET 0140-6736 (2019) DOI / 10.1016/s0140-6736(18)32470-x

Mentions 37 Twitter 0 Wikipedia 14 News 0 Policy

Article Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer Makker, Vicky; Taylor, Matthew H.; Aghajanian, Carol; Oaknin, Ana; Mier, James; Cohn, Allen L.; Romeo, Margarita; Bratos, Raquel; Brose, Marcia S.; Disimone, Christopher; Messing, Mark; Stepan, Daniel E.; Dutcus, Corina E.; Wu, Jane; Schmidt, Emmett V.; Or JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.19.02627 Green published, Gold other

Mentions 100 Twitter 0 Wikipedia 9 News 0 Policy

Article BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma Lin, Kevin K.; Harrell, Maria I.; Oza, Amit M.; Oaknin, Ana; Ray-Coquard, Isabelle; Tinker, Anna V.; Helman, Elena; Radke, Marc R.; Say, Carmen; Lan-Thanh Vo; Mann, Elaina; Isaacson, Jeffrey D.; Maloney, Lara; O'Malley, David M.; Chambers, Setsuko K.; Kauf CANCER DISCOVERY 2159-8274 (2019) DOI / 10.1158/2159-8290.cd-18-0715 Bronze

Mentions 14 Twitter 0 Wikipedia 16 News 0 Policy

Article Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial Oaknin, Ana; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Brana, Irene; Bidard, Francois-Clement; Goldman, Jonathan; Alvarez, Edwin A.; Boni, Valentina; ElNaggar, Adam C.; Passalacqua, Rodolfo; Do, Khanh T. M.; Santin, Alessandro D.; Keyvanjah, GYNECOLOGIC ONCOLOGY 0090-8258 (2020) DOI / 10.1016/j.ygyno.2020.07.025 Gold other

Mentions 4 Twitter 0 Wikipedia 23 News 0 Policy

Article Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer O'Malley, David M.; Oaknin, Ana; Monk, Bradley J.; Selle, Frederic; Rojas, Carlos; Gladieff, Laurence; Berton, Dominique; Leary, Alexandra; Moore, Kathleen N.; Estevez-Diz, Maria D. P.; Hardy-Bessard, Anne-Claire; Alexandre, Jerome; Opperman, Christina P.; GYNECOLOGIC ONCOLOGY 0090-8258 (2021) DOI / 10.1016/j.ygyno.2021.08.018 Hybrid

Mentions 68 Twitter 0 Wikipedia 11 News 0 Policy

Article Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2) Swisher, Elizabeth M.; Kwan, Tanya T.; Oza, Amit M.; Tinker, Anna, V; Ray-Coquard, Isabelle; Oaknin, Ana; Coleman, Robert L.; Aghajanian, Carol; Konecny, Gottfried E.; O'Malley, David M.; Leary, Alexandra; Provencher, Diane; Welch, Stephen; Chen, Lee-may; NATURE COMMUNICATIONS (2021) DOI / 10.1038/s41467-021-22582-6 Gold DOAJ, Green published

Mentions 130 Twitter 0 Wikipedia 4 News 0 Policy

Article Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial Banerjee, Susana; Moore, Kathleen N.; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S.; Gourley, Charlie; Oza, Amit; Gonzalez-Martin, Antonio; Agha LANCET ONCOLOGY 1470-2045 (2021) DOI / 10.1016/s1470-2045(21)00531-3

Mentions 31 Twitter 1 Wikipedia 9 News 0 Policy

Article Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial Naumann, R. Wendel; Hollebecque, Antoine; Meyer, Tim; Devlin, Michael-John; Oaknin, Ana; Kerger, Joseph; Lopez-Picazo, Jose M.; Machiels, Jean-Pascal; Delord, Jean-Pierre; Evans, Thomas R. J.; Boni, Valentina; Calvo, Emiliano; Topalian, Suzanne L.; Chen, T JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2019) DOI / 10.1200/jco.19.00739 Green published, Gold other, Green accepted

Mentions 61 Twitter 0 Wikipedia 6 News 1 Policy

Article Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) Tewari, Krishnansu S.; Sill, Michael W.; Penson, Richard T.; Huang, Helen; Ramondetta, Lois M.; Landrum, Lisa M.; Oaknin, Ana; Reid, Thomas J.; Leitao, Mario M.; Michael, Helen E.; DiSaia, Philip J.; Copeland, Larry J.; Creasman, William T.; Stehman, Frede LANCET 0140-6736 (2017) DOI / 10.1016/s0140-6736(17)31607-0 Green accepted, Green published

Mentions 137 Twitter 0 Wikipedia 1 News 0 Policy

Review A decade of clinical development of PARP inhibitors in perspective Mateo, J.; Lord, C. J.; Serra, V.; Tutt, A.; Balmana, J.; Castroviejo-Bermejo, M.; Cruz, C.; Oaknin, A.; Kaye, S. B.; de Bono, J. S. ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz192 Green published, Gold other

Mentions 75 Twitter 0 Wikipedia 3 News 0 Policy

Article Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib Kwan, Tanya T.; Oza, Amit M.; Tinker, Anna, V; Ray-Coquard, Isabelle; Oaknin, Ana; Aghajanian, Carol; Lorusso, Domenica; Colombo, Nicoletta; Dean, Andrew; Weberpals, Johanne; Severson, Eric; Lan-Thanh Vo; Goble, Sandra; Maloney, Lara; Harding, Thomas; Kauf JAMA ONCOLOGY 2374-2437 (2021) DOI / 10.1001/jamaoncol.2021.4664

Mentions 48 Twitter 0 Wikipedia 3 News 0 Policy

Article Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer A Nonrandomized Phase 1 Clinical Trial Oaknin, Ana; Tinker, Anna V.; Gilbert, Lucy; Samouelian, Vanessa; Mathews, Cara; Brown, Jubilee; Barretina-Ginesta, Maria-Pilar; Moreno, Victor; Gravina, Adriano; Abdeddaim, Cyril; Banerjee, Susana; Guo, Wei; Danaee, Hadi; Im, Ellie; Sabatier, Renaud JAMA ONCOLOGY 2374-2437 (2020) DOI / 10.1001/jamaoncol.2020.4515 Green published, Hybrid

Mentions 52 Twitter 0 Wikipedia 2 News 0 Policy

Article A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors Ligero, Marta; Garcia-Ruiz, Alonso; Viaplana, Cristina; Villacampa, Guillermo; Raciti, Maria, V; Landa, Jaid; Matos, Ignacio; Martin-Liberal, Juan; Ochoa-de-Olza, Maria; Hierro, Cinta; Mateo, Joaquin; Gonzalez, Macarena; Morales-Barrera, Rafael; Suarez, Cr RADIOLOGY 0033-8419 (2021) DOI / 10.1148/radiol.2021200928

Mentions 52 Twitter 0 Wikipedia 1 News 0 Policy

Article RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer Cruz, C.; Castroviejo-Bermejo, M.; Gutierrez-Enriquez, S.; Llop-Guevara, A.; Ibrahim, Y. H.; Gris-Oliver, A.; Bonache, S.; Morancho, B.; Bruna, A.; Rueda, O. M.; Lai, Z.; Polanska, U. M.; Jones, G. N.; Kristel, P.; de Bustos, L.; Guzman, M.; Rodriguez, O.; ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy099 Green published, Hybrid

Mentions 59 Twitter 0 Wikipedia 0 News 0 Policy

Review Endometrial cancer Makker, Vicky; Mackay, Helen; Ray-Coquard, Isabelle; Levine, Douglas A.; Westin, Shannon N.; Aoki, Daisuke; Oaknin, Ana NATURE REVIEWS DISEASE PRIMERS 2056-676X (2021) DOI / 10.1038/s41572-021-00324-8

Mentions 35 Twitter 0 Wikipedia 2 News 0 Policy

Article Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial Friedlander, Michael; Moore, Kathleen N.; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Lisyanskaya, Alla; Sonke, Gabe S.; Gourley, Charlie; Banerjee, Susana; Oza, Amit; Gonzalez-Martin, Antonio; Aghajanian, Carol; Bradley, William H LANCET ONCOLOGY 1470-2045 (2021) DOI / 10.1016/s1470-2045(21)00098-x

Mentions 68 Twitter 0 Wikipedia 0 News 0 Policy

Article Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria Matos, Ignacio; Martin-Liberal, Juan; Garcia-Ruiz, Alonso; Hierro, Cinta; Ochoa de Olza, Maria; Viaplana, Cristina; Azaro, Analia; Vieito, Maria; Brana, Irene; Mur, Gemma; Ros, Javier; Mateos, Jose; Villacampa, Guillermo; Berche, Roger; Oliveira, Mafalda; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-2226 Bronze

Mentions 30 Twitter 0 Wikipedia 3 News 1 Policy

Article Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial Swisher, Elizabeth M.; Lin, Kevin K.; Oza, Amit M.; Scott, Clare L.; Giordano, Heidi; Sun, James; Konecny, Gottfried E.; Coleman, Robert L.; Tinker, Anna V.; O'Malley, David M.; Kristeleit, Rebecca S.; Ma, Ling; Bell-McGuinn, Katherine M.; Brenton, James D LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(16)30559-9 Green accepted, Green published, Bronze

Mentions 43 Twitter 0 Wikipedia 0 News 0 Policy

Article Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials Dienstmann, Rodrigo; Garralda, Elena; Aguilar, Susana; Sala, Gemma; Viaplana, Cristina; Ruiz-Pace, Fiorella; Gonzalez-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Ramos Masdeu, Laia; Mancuso, Francesco; Fasani, Roberta; Jimenez, Jose; Mart JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.19.00398 Gold other, Green published

Mentions 38 Twitter 0 Wikipedia 1 News 1 Policy

Article Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I.; Clamp, Andrew R.; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W.; Gancedo, Margarita Amenedo; Fong, Peter C.; Goh, Jeffrey C JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.19.03107 Green published, Gold other

Mentions 35 Twitter 0 Wikipedia 1 News 0 Policy

Article EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression Lheureux, Stephanie; Oaknin, Ana; Garg, Swati; Bruce, Jeffrey P.; Madariaga, Ainhoa; Dhani, Neesha C.; Bowering, Valerie; White, Justin; Accardi, Sarah; Tan, Qian; Braunstein, Marsela; Karakasis, Katherine; Cirlan, Iulia; Pedersen, Stephanie; Li, Tiantiam; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-4121

Mentions 13 Twitter 0 Wikipedia 5 News 0 Policy

Article Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study Matulonis, U. A.; Shapira-Frommer, R.; Santin, A. D.; Lisyanskaya, A. S.; Pignata, S.; Vergote, I; Raspagliesi, F.; Sonke, G. S.; Birrer, M.; Provencher, D. M.; Sehouli, J.; Colombo, N.; Gonzalez-Martin, A.; Oaknin, A.; Ottevanger, P. B.; Rudaitis, V; Katc ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz135 Gold other, Green published

Mentions 54 Twitter 0 Wikipedia 0 News 0 Policy

Article Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ray-Coquard, I.; Morice, P.; Lorusso, D.; Prat, J.; Oaknin, A.; Pautier, P.; Colombo, N. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy001 Bronze

Mentions 29 Twitter 0 Wikipedia 1 News 0 Policy

Article FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer Moore, Kathleen N.; Vergote, Ignace; Oaknin, Ana; Colombo, Nicoletta; Banerjee, Susana; Oza, Amit; Pautier, Patricia; Malek, Karim; Birrer, Michael J. FUTURE ONCOLOGY 1479-6694 (2018) DOI / 10.2217/fon-2017-0646 Gold other

Mentions 39 Twitter 0 Wikipedia 0 News 0 Policy

Article Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials Matos, Ignacio; Villacampa, Guillermo; Hierro, Cinta; Martin-Liberal, Juan; Berche, Roger; Pedrola, Anna; Brana, Irene; Azaro, Analia; Vieito, Maria; Saavedra, Omar; Gardeazabal, Itziar; Hernando-Calvo, Alberto; Alonso, Guzman; Galvao, Vladimir; de Olza, M EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.05.040 Hybrid

Mentions 1 Twitter 0 Wikipedia 2 News 0 Policy

Editorial Material VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma Tewari, K. S.; Monk, B. J.; Vergote, I.; Miller, A.; De Melo, A. C.; Kim, H. S.; Kim, Y. M.; Lisyanskaya, A.; Samouelian, V.; Lorusso, D.; Damian, F.; Chang, C-L.; Gotovkin, E. A.; Takahashi, S.; Ramone, D.; Pikiel, J.; Li, J.; Mathias, M.; Fury, M. G.; Oa ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.04.009 Bronze

Mentions 60 Twitter 0 Wikipedia 0 News 0 Policy

Article Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3 Clamp, Andrew R.; Lorusso, Domenica; Oza, Amit M.; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne, I; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W.; Gancedo, Margarita Amenedo; Fong, Peter C.; Goh, Jeffrey C INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 1048-891X (2021) DOI / 10.1136/ijgc-2020-002240 Green submitted, Bronze

Mentions 32 Twitter 0 Wikipedia 0 News 0 Policy

Article Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial Disilvestro, Paul; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S.; Gourley, Charlie; Banerjee, Susana; Oza, Amit; Gonzalez-Martin, Antonio; Aghaj JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.20.00799

Mentions 3 Twitter 0 Wikipedia 1 News 0 Policy

Article Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2 Oza, Amit M.; Tinker, Anna V.; Oaknin, Ana; Shapira-Frommer, Ronnie; McNeish, Lain A.; Swisher, Elizabeth M.; Ray-Coquard, Isabelle; Bell-McGuinn, Katherine; Coleman, Robert L.; O'Malley, David M.; Leary, Alexandra; Chen, Lee-may; Provencher, Diane; Ma, Li GYNECOLOGIC ONCOLOGY 0090-8258 (2017) DOI / 10.1016/j.ygyno.2017.08.022 Gold other, Green accepted, Green published

Mentions 18 Twitter 0 Wikipedia 0 News 0 Policy

Article Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer Oaknin, Ana; Tinker, Anna, V; Gilbert, Lucy; Samouelian, Vanessa; Mathews, Cara; Brown, Jubilee; Barretina-Ginesta, Maria-Pilar; Moreno, Victor; Gravina, Adriano; Abdeddaim, Cyril; Banerjee, Susana; Guo, Wei; Danaee, Hadi; Im, Ellie; Sabatier, Renaud FUTURE ONCOLOGY 1479-6694 (2021) DOI / 10.2217/fon-2021-0598 Hybrid

Mentions 9 Twitter 0 Wikipedia 1 News 0 Policy

Article Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial Colombo, Nicoletta; Moore, Kathleen; Scambia, Giovanni; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S.; Gourley, Charlie; Banerjee, Susana; Oza, Amit; Gonzalez-Martin, Antonio; Aghajanian, Carol; Bradl GYNECOLOGIC ONCOLOGY 0090-8258 (2021) DOI / 10.1016/j.ygyno.2021.07.016 Hybrid, Green published

Mentions 6 Twitter 0 Wikipedia 1 News 0 Policy

Review First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion Banerjee, Susana; Gonzalez-Martin, Antonio; Harter, Philipp; Lorusso, Domenica; Moore, Kathleen N.; Oaknin, Ana; Ray-Coquard, Isabelle ESMO OPEN (2020) DOI / 10.1136/esmoopen-2020-001110 Green published, Gold

Mentions 3 Twitter 0 Wikipedia 1 News 0 Policy

Article Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I Moore, K. N.; Oza, A. M.; Colombo, N.; Oaknin, A.; Scambia, G.; Lorusso, D.; Konecny, G. E.; Banerjee, S.; Murphy, C. G.; Tanyi, J. L.; Hirte, H.; Konner, J. A.; Lim, P. C.; Prasad-Hayes, M.; Monk, B. J.; Pautier, P.; Wang, J.; Berkenblit, A.; Vergote, I; ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.02.017 Gold other

Mentions 2 Twitter 0 Wikipedia 0 News 0 Policy

Article Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab Makker, Vicky; Taylor, Matthew H.; Oaknin, Ana; Casado Herraez, Antonio; Orlowski, Robert; Dutta, Lea; Ren, Min; Zale, Melissa; O'Malley, David M. ONCOLOGIST 1083-7159 (2021) DOI / 10.1002/onco.13883 Hybrid

Mentions 12 Twitter 0 Wikipedia 0 News 0 Policy

Article SEOM clinical guidelines for cervical cancer (2019) de Juan, A.; Redondo, A.; Rubio, M. J.; Garcia, Y.; Cueva, J.; Gaba, L.; Yubero, A.; Alarcon, J.; Maximiano, C.; Oaknin, A. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-019-02271-z Gold other

Mentions 1 Twitter 0 Wikipedia 1 News 0 Policy

Article ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian ca Monk, Bradley J.; Coleman, Robert L.; Fujiwara, Keiichi; Wilson, Michelle K.; Oza, Amit M.; Oaknin, Ana; O'Malley, David M.; Lorusso, Domenica; Westin, Shannon N.; Safra, Tamar; Herzog, Thomas J.; Marme, Frederik; Eskander, Ramez; Lin, Kevin K.; Shih, Dann INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 1048-891X (2021) DOI / 10.1136/ijgc-2021-002933 Hybrid

Mentions 7 Twitter 0 Wikipedia 0 News 0 Policy

Article Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL) Gaillard, Stephanie; Oaknin, Ana; Ray-Coquard, Isabelle; Vergote, Ignace; Scambia, Giovanni; Colombo, Nicoletta; Fernandez, Cristian; Alfaro, Vicente; Kahatt, Carmen; Nieto, Antonio; Zeaiter, Ali; Aracil, Miguel; Vidal, Laura; Pardo-Burdalo, Beatriz; Papai GYNECOLOGIC ONCOLOGY 0090-8258 (2021) DOI / 10.1016/j.ygyno.2021.08.032

Mentions 4 Twitter 0 Wikipedia 0 News 0 Policy

Article Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer Felip, Isidre; Pablo Moiola, Cristian; Megino-Luque, Cristina; Lopez-Gil, Carlos; Cabrera, Silvia; Sole-Sanchez, Sonia; Munoz-Guardiola, Pau; Megias-Roda, Elisabet; Perez-Montoyo, Hector; Alfon, Jose; Yeste-Velasco, Marc; Santacana, Maria; Dolcet, Xavier; GYNECOLOGIC ONCOLOGY 0090-8258 (2019) DOI / 10.1016/j.ygyno.2019.03.002

Mentions 8 Twitter 0 Wikipedia 0 News 0 Policy

Review PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations Vanacker, Helene; Harter, Philipp; Labidi-Galy, Sana Intidhar; Banerjee, Susana; Oaknin, Ana; Lorusso, Domenica; Ray-Coquard, Isabelle CANCER TREATMENT REVIEWS 0305-7372 (2021) DOI / 10.1016/j.ctrv.2021.102255

Mentions 9 Twitter 0 Wikipedia 0 News 0 Policy

Article Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer Rodriguez-Freixinos, Victor; Ruiz-Pace, Fiorella; Farinas-Madrid, Lorena; Garrido-Castro, Ana Christina; Villacampa, Guillermo; Nuciforo, Paolo; Vivancos, Ana; Dienstmann, Rodrigo; Oaknin, Ana ESMO OPEN (2019) DOI / 10.1136/esmoopen-2018-000444 Gold DOAJ, Green published

Mentions 9 Twitter 0 Wikipedia 0 News 0 Policy

Article Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study Chase, Dana; Huang, Helen Q.; Monk, Bradley J.; Ramondetta, Lois Michelle; Penson, Richard T.; Gil, Karen; Landrum, Lisa M.; Leitao, Mario; Oaknin, Ana; Huh, Warner K.; Pulaski, Heather L.; Robison, Katina; Guntupalli, Saketh R.; Richardson, Debra; Salani, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 1048-891X (2020) DOI / 10.1136/ijgc-2019-000869

Mentions 7 Twitter 0 Wikipedia 0 News 0 Policy

Article Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients Rodriguez-Freixinos, V.; Farinas-Madrid, L.; Gil-Martin, M.; Barretina-Ginesta, P.; Romeo, M.; Villacampa, G.; Pardo, B.; Ahmed, H.; Recalde, S.; Piulats, J. M.; Gomez-Plaza, M. C.; Gil-Moreno, A.; Sala, E.; Martinez-Roman, S.; Ponce, J.; Melendez, C.; Car GYNECOLOGIC ONCOLOGY 0090-8258 (2019) DOI / 10.1016/j.ygyno.2018.11.036

Mentions 1 Twitter 2 Wikipedia 0 News 0 Policy

Article A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer Pautier, Patricia; Vergote, Ignace; Joly, Florence; Melichar, Bohuslav; Kutarska, Elzbieta; Hall, Geoffrey; Lisyanskaya, Anna; Reed, Nicholas; Oaknin, Ana; Ostapenko, Valerijus; Zvirbule, Zanete; Chetaille, Eric; Geniaux, Agnes; Shoaib, Muhammad; Green, Jo INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 1048-891X (2017) DOI / 10.1097/igc.0000000000000862

Mentions 1 Twitter 0 Wikipedia 0 News 1 Policy

Article Radical Hysterectomy: Efficacy and Safety in the Dawn of Minimally Invasive Techniques Gil-Moreno, Antonio; Carbonell-Socias, Melchor; Salicru, Sabina; Centeno-Mediavilla, Cristina; Franco-Camps, Silvia; Colas, Eva; Oaknin, Ana; Perez-Benavente, Assumpcio; Diaz-Feijoo, Berta JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY 1553-4650 (2019) DOI / 10.1016/j.jmig.2018.06.007

Mentions 7 Twitter 0 Wikipedia 0 News 0 Policy

Article A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors Poveda, Andres; Oaknin, Ana; Romero, Ignacio; Guerrero-Zotano, Angel; Farinas-Madrid, Lorena; Rodriguez-Freixinos, Victor; Mallol, Pedro; Lopez-Reig, Raquel; Antonio Lopez-Guerrero, Jose SCIENTIFIC REPORTS 2045-2322 (2021) DOI / 10.1038/s41598-021-82671-w Gold DOAJ, Green published

Mentions 5 Twitter 0 Wikipedia 0 News 0 Policy

Article Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study Seamon, Leigh G.; Java, James J.; Monk, Bradley J.; Penson, Richard T.; Brown, Jubilee; Mannel, Robert S.; Oaknin, Anna; Leitao, Mario M.; Eisenhauer, Eric L.; Long, Harry J.; Liao, Shu Y.; Tewari, Krishnansu S. BRITISH JOURNAL OF CANCER 0007-0920 (2018) DOI / 10.1038/bjc.2017.400 Green published, Gold other

Mentions 6 Twitter 0 Wikipedia 0 News 0 Policy

Article A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc stu Francisco Grau, Juan; Farinas-Madrid, Lorena; Oaknin, Ana INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 1048-891X (2020) DOI / 10.1136/ijgc-2019-000880

Mentions 4 Twitter 0 Wikipedia 0 News 0 Policy

Article ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma Liu, Joyce; Oza, Amit M.; Colombo, Nicoletta; Oaknin, Ana INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 1048-891X (2021) DOI / 10.1136/ijgc-2021-003144

Mentions 4 Twitter 0 Wikipedia 0 News 0 Policy

Article Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10 Drew, Yvette; Kristeleit, Rebecca S.; Oaknin, Ana; Ray-Coquard, Isabelle; Haris, Noor Md.; Swisher, Elizabeth M. ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2019-0229 Green published, Hybrid

Mentions 3 Twitter 0 Wikipedia 0 News 0 Policy

Article The genetic landscape of 87 ovarian germ cell tumors van Nieuwenhuysen, Els; Busschaert, Pieter; Neven, Patrick; Han, Sileny N.; Moerman, Philippe; Liontos, Michalis; Papaspirou, Maria; Kupryjanczyk, Jolanta; Hogdall, Claus; Hogdall, Estrid; Oaknin, Ana; Garcia, Angel; Mahner, Sven; Trillsch, Fabian; Cibula, GYNECOLOGIC ONCOLOGY 0090-8258 (2018) DOI / 10.1016/j.ygyno.2018.08.013

Mentions 5 Twitter 0 Wikipedia 0 News 0 Policy

Article Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062) Tewari, Krishnansu S.; Sill, Michael W.; Monk, Bradley J.; Penson, Richard T.; Moore, David H.; Lankes, Heather A.; Ramondetta, Lois M.; Landrum, Lisa M.; Randall, Leslie M.; Oaknin, Ana; Leitao, Mario M.; Eisenhauer, Eric L.; Disilvestro, Paul; Van Le, Li MOLECULAR CANCER THERAPEUTICS 1535-7163 (2020) DOI / 10.1158/1535-7163.mct-20-0276

Mentions 6 Twitter 0 Wikipedia 0 News 0 Policy

Article Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study) Perez-Fidalgo, J. A.; Cortes, A.; Guerra, E.; Garcia, Y.; Iglesias, M.; Sarmiento, U. Bohn; Garcia, E. Calvo; Sanchez, L. Manso; Santaballa, A.; Oaknin, A.; Redondo, A.; Rubio, M. J.; Gonzalez-Martin, A. ESMO OPEN (2021) DOI / 10.1016/j.esmoop.2021.100212 Gold, Green published